Home › Funds › Palo Alto Investors LP › ACRS

Palo Alto Investors LP position in ACRS

ACLARIS THERAPEUTICS INC · Health Care

Palo Alto Investors LP reported holding 1,156,396 shares of ACRS (ACLARIS THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$6.1M, representing 0.90% of its reported portfolio and ranking #26 among its reported holdings. Palo Alto Investors LP has disclosed ACRS holdings in 11 of the last 11 reported quarters, going back to Q1 2024.

Latest position (Q3 2026)1.16M sh
Reported value held$6.08M
Portfolio Weight0.90%
First reportedQ1 2024
Last changeReduce
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Palo Alto Investors LP's ACRS position evolved

Palo Alto Investors LP first disclosed a stake in ACRS in Q1 2024 at 569,832 shares (US$707K). The position peaked in Q2 2026 at 1,613,430 shares, worth US$8.5M. Across 11 filings, Palo Alto Investors LP increased the stake 4 time(s), trimmed it 1 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 1,156,396 shares valued at US$6.1M — a reduction of -457,034 shares quarter over quarter.. Notable position changes include a 36% increase in Q1 2025 (shares fell 7% over the following quarter), a 79% increase in Q2 2025 (shares rose 34% over the following quarter), a 28% trim in Q3 2026 (shares fell 31% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2024 569.83K $706.59K New
Q2 2024 569.83K $626.82K Hold
Q3 2024 569.83K $655.31K Hold
Q4 2024 569.83K $1.41M Hold
Q1 2025 776.03K $1.19M Add
Q2 2025 1.39M $1.97M Add
Q3 2025 1.57M $2.98M Add
Q4 2025 1.57M $4.72M Hold
Q1 2026 1.61M $6.05M Add
Q2 2026 1.61M $8.54M Hold
Q3 2026 1.16M $6.08M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ACRS and 13F data

ACRS (ACLARIS THERAPEUTICS INC) is a Health Care company. 46 other funds we track also report a position in ACRS — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$66.9M), BML Capital Management, LLC (US$57.6M), Deep Track Capital, LP (US$49.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ACRS

All ACRS fund holders →

FAQ

How long has Palo Alto Investors LP held ACRS?

Palo Alto Investors LP has disclosed ACRS holdings in 11 of the last 11 reported quarters, going back to Q1 2024.

What is Palo Alto Investors LP's current position in ACRS?

As of Q3 2026, Palo Alto Investors LP holds 1.16M shares of ACRS (ACLARIS THERAPEUTICS INC), valued at $6.08M, representing 0.90% of its reported portfolio and ranking #26.

Has Palo Alto Investors LP been buying or selling ACRS?

In the latest 13F filing (Q3 2026), Palo Alto Investors LP reduced its position in ACRS. The position peaked in Q2 2026 at 1.61M shares.

Which other funds hold ACRS?

Other major institutional holders of ACRS include RA CAPITAL MANAGEMENT, L.P., BML Capital Management, LLC, Deep Track Capital, LP, among 46 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.